Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.

Castle PE, Gage JC, Wheeler CM, Schiffman M.

Obstet Gynecol. 2011 Dec;118(6):1222-9. doi: 10.1097/AOG.0b013e318237caf4.

2.
3.
5.

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.

Castle PE, Solomon D, Schiffman M, Wheeler CM.

J Natl Cancer Inst. 2005 Jul 20;97(14):1066-71.

PMID:
16030304
6.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.

Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7.

PMID:
21865084
7.

Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.

Li K, Yin R.

Medicine (Baltimore). 2015 Feb;94(5):e435. doi: 10.1097/MD.0000000000000435.

8.

The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.

Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N.

Cancer Cytopathol. 2013 Feb;121(2):79-85. doi: 10.1002/cncy.21240.

9.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
10.

Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.

Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1675-81. doi: 10.1158/1055-9965.EPI-10-0251.

11.

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

ASCUS-LSIL Traige Study (ALTS) Group..

Am J Obstet Gynecol. 2003 Jun;188(6):1383-92.

PMID:
12824967
12.
13.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
14.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
15.

Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.

Yang L, He Z, Huang XY, Liu HN, Tao JY.

Eur J Gynaecol Oncol. 2015;36(1):73-7.

PMID:
25872339
16.
17.

Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.

Pierry D, Weiss G, Lack B, Chen V, Fusco J.

Arch Pathol Lab Med. 2012 Aug;136(8):956-60. doi: 10.5858/arpa.2011-0180-OA.

PMID:
22849745
19.

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD.

J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001.

Supplemental Content

Support Center